Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026)
Mereo BioPharma (MREO) reported Exchange Rate Effect of -$157000.0 for Q1 2026, down 117.29% year-over-year from $908000.0 in Q1 2025, and down 149.21% quarter-over-quarter from -$63000.0 in Q4 2025.
Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Exchange Rate Effect data on file, last reported at -$157000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$157000.0, down 117.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $789000.0 (up 5.91% YoY), and the FY2025 annual result was $1.9 million, up 895.71% from the prior year.
- Exchange Rate Effect fell to -$157000.0 in Q1 2026 per MREO's latest filing, from -$63000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1.7 million in Q4 2023 and troughed at -$1.3 million in Q4 2024.
- A 4-year average of $329384.6 and a median of -$63000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect sank 174.91% in 2024, then jumped 1433.64% in 2025.
- A 4-year view of Exchange Rate Effect shows it stood at $1.7 million in 2023, then slumped by 174.91% to -$1.3 million in 2024, then soared by 95.0% to -$63000.0 in 2025, then tumbled by 149.21% to -$157000.0 in 2026.
- Business Quant data shows MREO's Exchange Rate Effect at -$157000.0 in Q1 2026, -$63000.0 in Q4 2025, and -$418000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157,000.00 |
| Mar 31, 2026 | -157,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 908,000.00 |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -107,000.00 |
| Jun 30, 2024 | -107,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Dec 31, 2023 | 1.68 Mn |